Five-Year Trade Duty Checkups Kick Off Automatically
Published Date: 9/1/2026
Notice
Summary
In accordance with the Tariff Act of 1930, as amended (the Act), the U.S. Department of Commerce (Commerce) is automatically initiating the five-year reviews (Sunset Reviews) of the antidumping duty (AD) and countervailing duty (CVD) orders and suspended investigations listed below. The U.S. International Trade Commission (ITC) is publishing concurrently with this notice its notice of Institution of Five-Year Reviews which covers the same orders and suspended investigations.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 2 costs, 1 mixed.
Orders auto‑revoked if no domestic party files
If no domestic interested party files a notice of intent to participate by the 15th day after this notice's Federal Register publication, Commerce will automatically revoke the order without further review. Domestic parties must file that notice within 15 days to avoid automatic revocation.
Tight filing, certification, and APO rules
Parties wishing to participate must file a notice of intent within 15 days and complete substantive responses within 30 days after this notice's publication. All submissions must follow Commerce's filing rules (including electronic filing via ACCESS) and be received by ACCESS by 5:00 p.m. Eastern Time on the due date. Factual information must include the certification formats in 19 CFR 351.303(g); Commerce intends to reject factual submissions that do not comply. Parties wanting proprietary access should file an administrative protective order application immediately and are requested to submit an entry of appearance within 10 days.
Commerce starts five‑year trade reviews
Commerce is initiating five‑year (Sunset) reviews effective September 1, 2026 for specified antidumping and countervailing duty orders covering petroleum wax candles from China and polyethylene retail carrier bags from China, Indonesia, Malaysia, Taiwan, Thailand, and Vietnam. The International Trade Commission published a matching notice covering the same orders.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17888, Welded Line Pipe From the Republic of Türkiye: Final Results of the Expedited Second Sunset Review of the Countervailing Duty Order
The U.S. Department of Commerce (Commerce) finds that revocation of the countervailing duty (CVD) order on welded line pipe from the Republic of T[uuml]rkiye (T[uuml]rkiye) would be likely to lead to continuation or recurrence of countervailable subsidies at the levels indicated in the "Final Results of Sunset Review" section of this notice.
2026-17768, Certain Cold-Rolled Steel Flat Products From the Republic of Korea: Final Results of Countervailing Duty Administrative Review; 2023
The U.S. Department of Commerce (Commerce) determines Hyundai Steel Company (Hyundai Steel) and POSCO, producers/exporters of certain cold-rolled steel flat products (cold-rolled steel) from the Republic of Korea (Korea), received countervailable subsidies during the period of review (POR) January 1, 2023, through December 31, 2023.
2026-17769, Ammonium Sulfate From People's Republic of China: Notice of Court Decision Not in Harmony With Final Scope Ruling and Notice of Amended Final Scope Ruling Pursuant to Court Decision
On August 12, 2026, the U.S. Court of International Trade (CIT or the Court) issued its final judgment in Cambridge Isotope Laboratories, Inc. v. United States, Court No. 23-00080 sustaining the U.S. Department of Commerce (Commerce)'s remand redetermination pertaining to the scope ruling for the antidumping and countervailing duty orders on Ammonium Sulfate from People's Republic of China finding enriched \15\N ammonium sulfate isotope to be included in the orders. Commerce is notifying the public that the CIT's final judgment is not in harmony with Commerce's scope ruling, and that Commerce is amending the scope ruling to find that enriched \15\N ammonium sulfate isotope is outside the scope of the orders.
2026-17817, Perfluoroalkoxy Alkane From India: Initiation of Countervailing Duty Investigation
2026-17772, Light-Walled Rectangular Pipe and Tube From the People's Republic of China, Mexico, the Republic of Korea, and the Republic of Türkiye: Continuation of Antidumping Duty Orders and Countervailing Duty Order
As a result of the determinations by the U.S. Department of Commerce (Commerce) and the U.S. International Trade Commission (ITC) that revocation of the antidumping duty (AD) orders and countervailing duty (CVD) order on light-walled rectangular pipe and tube (light- walled pipe and tube) from the People's Republic of China (China) (AD/ CVD), Mexico (AD), the Republic of Korea (Korea) (AD) and the Republic of T[uuml]rkiye (T[uuml]rkiye) (AD) would likely lead to the continuation or recurrence of dumping, countervailable subsidies, and material injury to an industry in the United States, Commerce is publishing a notice of continuation of these AD and CVD orders.
2026-17794, Certain Choline Salts From the People's Republic of China: Postponement of Preliminary Determination in the Countervailing Duty Investigation
The U.S. is investigating certain choline salts from China to see if unfair government help is involved. The first big decision on this is delayed from September 17 to a later date because the case is tricky and needs more time. This affects companies importing these salts and could lead to extra fees if unfair support is found.
Previous / Next Documents
Previous: 2026-17810, Antidumping or Countervailing Duty Order, Finding, or Suspended Investigation; Opportunity To Request Administrative Review and Join Annual Inquiry Service List; Note Regarding Format of Review Requests
Next: 2026-17812, Determination That NAMENDA (Memantine Hydrochloride) Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA, Agency, or we) has determined that NAMENDA (memantine hydrochloride) tablets, 5 milligrams (mg) and 10 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as the ANDAs meet relevant legal and regulatory requirements.